These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27834149)

  • 1. Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology.
    Kong H; Yu F; Liu Y; Yang Y; Li M; Cheng X; Hu X; Tang X; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):44-51. PubMed ID: 27834149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology.
    Zhao S; Yu F; Liu N; Di Z; Yan K; Liu Y; Li Y; Zhang H; Yang Y; Yang Z; Li Z; Mei X
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1723-31. PubMed ID: 27074758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
    Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
    Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation.
    He Z; Zhong D; Chen X; Liu X; Tang X; Zhao L
    Eur J Pharm Sci; 2004 Mar; 21(4):487-91. PubMed ID: 14998579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs.
    Li Z; Yu F; Di Z; Zhao X; Zhao S; Liu Y; Li Y; Wang Z; Gong W; Zhang H; Yang Y; Xie X; Mei X
    Drug Dev Ind Pharm; 2016 Jan; 42(1):12-18. PubMed ID: 25830369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
    Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
    AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Liquid Oral Mucoadhesive Gastro-retentive System of Nimodipine.
    Mamdouh M; Donia A; Essa E; Maghraby GE
    Curr Drug Deliv; 2019; 16(9):862-871. PubMed ID: 31633475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study and Evaluation on Preparation of Monolithic Osmotic Pump Tablet of Resveratrol].
    Wu XC; Hao HJ; Song XY; Zhang YZ; Liu YX; Zhang HQ
    Zhong Yao Cai; 2015 Aug; 38(8):1732-5. PubMed ID: 26983250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on nimodipine sustained-release tablet capable of floating on gastric fluid with prolonged gastric resident time].
    Wu W; Zhou Q; Zhang HB; Ma GD; Fu CD
    Yao Xue Xue Bao; 1997 Oct; 32(10):786-90. PubMed ID: 11596225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
    Li XD; Pan WS; Nie SF; Wu LJ
    J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel buccal adhesive system for anti-hypertensive agent nimodipine.
    Hassan N; Ali M; Ali J
    Pharm Dev Technol; 2010; 15(2):124-30. PubMed ID: 19911950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
    Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
    Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.